Drug Shortage Report for HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE INJECTION
Report ID | 146019 |
Drug Identification Number | 01990748 |
Brand name | HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE INJECTION |
Common or Proper name | Heparin Sodium In Sodium Chloride Injection |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | HEPARIN SODIUM |
Strength(s) | 2UNIT |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 12 x 1L bag |
ATC code | B01AB |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-09-27 |
Estimated end date | |
Actual end date | 2021-11-03 |
Shortage status | Resolved |
Updated date | 2021-11-04 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2021-11-04 | English | Compare |
v9 | 2021-11-03 | French | Compare |
v10 | 2021-11-03 | French | Compare |
v8 | 2021-11-03 | English | Compare |
v7 | 2021-10-06 | French | Compare |
v6 | 2021-10-06 | English | Compare |
v5 | 2021-09-28 | French | Compare |
v4 | 2021-09-28 | English | Compare |
v3 | 2021-09-28 | English | Compare |
v2 | 2021-09-22 | French | Compare |
v1 | 2021-09-22 | English | Compare |
Showing 1 to 11 of 11